The webinar will consider questions such as how practices can maintain turnover whilst sticking to the government and regulator guidelines, and how this can be done without compromising the customer experience.
Hosted by Past President of the British Veterinary Association Gudrun Ravetz, three additional veterinary business experts - Brian Faulkner, Alison Lambert and Alan Robinson - will come together to share their advice on how to minimise the impact that coronavirus has on the practice, the team and a practice’s clients.
Veterinary professionals can submit questions directly to the panel who will answer them during the live event.
To register for the webinar, visit the Boehringer www.boehringer-academy.co.uk.
The series will start on Sunday February 27th when Katie Ford MRCVS, who is also a life coach, will discuss the benefits of 'gratitude practice' in a 'Facebook Live' session starting at 8:00pm.
Thereafter, there will be a further seven 30-minute sessions:
Liz Barton, co-founder of WellVet, said: "We were blown away by the positive response to the Winter Wellbeing series and want to continue to build more tools and content to help people through what has already been a tough start to 2021. Our emphasis is on simple, practical, accessible tips to improve personal and team wellbeing.”
Emma McAnally, territory manager at Boehringer Ingelheim Animal Health said: “Spring is the ideal time to hit refresh on your mental and physical wellbeing. So we felt that this series will help to shed the winter blues, re-energise the team and offer an opportunity for the veterinary community to come together and take forward positive wellbeing practices. We’re delighted to support WellVet again in bringing this Spring series to life.”
For further information on the WellVet Winter Wellbeing series and for details on how to join visit www.wellvet.co.uk.
Police have advised veterinary practices to be on their guard following a spate of break-ins in the South East, linked to the theft of controlled drugs.
PC Steve Doswell, Controlled Drugs Liaison Officer in the East Sussex police area said: "Criminal elements in the South East are targeting practices in Surrey, Hampshire and East Sussex. They may well have targeted, or will target, other practices in all of the neighbouring counties".
"Methadone, Ketamine, Alprazolam and Diazepam are all commonly-abused by drug users, and nationally there have been a lot of problems with users buying street heroin that has been cut with Alprazolam," he added.
PC Doswell offered the following advice to practices:
More detailed information about the correct storage of controlled drugs can be found in the RCVS Practice Standards Scheme Manual: www.rcvs.org.uk/practicestandards
A new animal welfare report by the PDSA has revealed that millions of pets are more aggressive, overweight and misunderstood than ever due to fundamental gaps in pet owners' animal welfare knowledge.
The PDSA Animal Wellbeing (PAW) report, which captures the views of pet owners, the veterinary profession and children, reveals that 1.3 million dogs across the UK are displaying problem behaviour. It also highlights the consequences of an obesity epidemic affecting 18.5 million dogs, cats and rabbits, and draws attention to the 11.2 million pets not registered with a vet and therefore at risk of disease due to not being vaccinated or neutered.
The BVA is urging veterinary surgeons and nurses to read the report which identifies where owners are misinformed or unaware and highlights areas that everyone can work on with their clients to help achieve better wellbeing for pets.
Peter Jones, President of the BVA, said: "This is another excellent report from the PDSA offering real insight into clients' motivations. Understanding what drives owners' attitudes, as well as helping them to understand key health and welfare issues, should help us to clarify misconceptions in the consulting room and hopefully change behaviour at home.
"On the positive side, with pet obesity ever rising it is good to see that there is a slight increase in the proportion of owners starting to recognise obesity in their pets. This is, no doubt, in part due to the tireless work of charities like the PDSA and the veterinary profession as a whole.
"Sadly, despite most owners' awareness of the ill effect that bad nutrition has on their pet this has not led to them cutting out pet treats. The fact that few can identify a healthy body shape shows that much remains to be done.
"The section on preventive healthcare remains worrying with many owners seemingly not believing in the concepts of microchipping, neutering and vaccination. Vets have a real responsibility to help communicate these issues to the pet owning public for the benefit of both clients and their animals.
"The report very clearly identifies where owners are misinformed or unaware and highlights areas that vets in practice can work on with their clients to help achieve better wellbeing for pets.
"The report is very clearly laid out and well worth a read. We would encourage all vets to take a look and identify any new educational resources to promote in the practice, in newsletters and on websites in addition to the ones they already make available to clients. The AWF leaflets, the PDSA's own website, and the Education Alliance are all good starting points."
Click here for the report.
The RCVS has launched a survey asking recent graduates from UK veterinary schools to share their experiences of the role played by extra-mural studies (EMS) while studying for their degree.
The aim of the online survey, which has been emailed to all of the 2012 and 2013 UK veterinary graduates for whom the College holds email addresses, is to take a snapshot of how EMS placements - whether pre-clinical or clinical - are working in practice and their value in educational terms.
Christine Warman, RCVS Head of Education, said: "In 2009 we carried out a review into EMS arrangements and, in light of this, we want to gather evidence on current practice in order to build up a picture of how EMS is now working and the role that it plays in the learning process for veterinary students. This evidence will inform any future discussions about EMS.
"So, for example, we would like to find out what students gained from EMS that they could not have learnt from their core studies alone and gather further information on the process of identifying and arranging EMS placements."
Recent graduates taking part in the survey, which takes around 10 to 15 minutes to complete, can supply their name and email address or, alternatively, there is the option of responding anonymously. The survey should be completed by Friday 14 February. Those 2012 and 2013 graduates who have not received an email with the link to the survey, and who wish to take part, should email: education@rcvs.org.uk
For more information on EMS, or the survey, contact the RCVS Education Department on 020 7202 0791 or education@rcvs.org.uk. Further guidance about EMS for both students and placement providers can be found at www.rcvs.org.uk/ems which includes a link to the RCVS Find a Vet service where students can search for practices providing EMS.
Orthomed has announced the launch of a series of four webinars covering a range of orthopaedic subjects.
The webinars are being presented by global diplomates and hosted by The Webinar Vet. They are:
Orthomed says the presentations are suitable for orthopaedic surgeons of all levels and interests, as well as those looking to get more involved in orthopaedic surgery.
The webinars are being held monthly, starting at the end of March.
The webinar series costs £97, which includes a £150 voucher to redeem against an Orthomed workshop.
In addition, the Webinar Vet has made 15 tickets available free of charge. To see if you can claim one, email Orthomed at info@orthomed.co.uk with the subject title Orthopaedic Webinar.
For more information, visit: https://www.thewebinarvet.com/orthopaedicexpertise
For the study, titled “RHDV2 epidemic in UK pet rabbits. Part 1: clinical features, gross post mortem and histopathological findings”1, veterinary surgeons were encouraged to submit case histories and the results of post mortem examinations of pet rabbits that died suddenly. Samples taken during the post mortem were sent for histopathological examination.
Frances Harcourt-Brown, corresponding author for the paper, said: "Case histories, macroscopic findings and histopathology results were available from 300 rabbits that died suddenly.
"Of these, 185 (62%) died from RHD and showed characteristic histopathological features of RHD including apoptosis and variable lytic and coagulative hepatocellular necrosis, with varying distribution.
"Interestingly, macroscopic evidence of disease was not present in all cases – for example, gross liver abnormalities were only reported in 30% of cases, despite all cases showing hepatocellular necrosis on microscopic examination.
"Rapid death and death of other rabbits in the household were common features of RHD.
"Histopathology was also useful in yielding valuable information about other causes of death in the rabbits that did not die from RHD.”
Nicola Di Girolamo, editor of JSAP said: “This is a terrible disease that is currently spreading in areas of the world that were free from it until recently. Having more evidence on the type of clinical presentations and lesions that should be expected with this disease in rabbit patients is going to be of tremendous value for clinicians. Given that there is not always macroscopic evidence of RHD, histopathology is key for the diagnosis of RHD in pet rabbits.”
The full article can be found in the July issue of the Journal of Small Animal Practice which is free for BSAVA members.
It can also be read online here: https://www.onlinelibrary.wiley.com/doi/full/10.1111/jsap.13141
Reference
Photo: BSAVA
The five-minute survey includes questions on the number of otitis externa cases seen in practice, consultation times, common compliance issues, cytology uptake and client behaviour change frameworks.
Completed entries will be entered into a draw for a Fortnum & Mason hamper worth £100.
Charlotte Hill, brand manager at Dechra said: “The otitis externa in dogs survey will provide us with valuable insight into vets’ experiences of the condition.
"It will also allow us to identify any trends that may exist to help us improve how we as a profession approach otitis externa, while supporting owners when treating the condition which can be frustrating to manage.
https://forms.office.com/e/J7frrbL56A
To coincide with National Microchipping Month in June this year, Avid will update the details of any pet with an Avid microchip registered on the UK 24hr PETtrac microchip database free of charge, saving their owner £6 for a change of address and £12 for a change of ownership.
In addition, anyone who contacts the company via its website during June will also be entered into a prize draw to win one year's worth of free pet insurance.
To update registration details free of charge, visit www.petchipupdate.com (the update service activates in June), or call 0800 652 8977.
Any microchipper who would like a Pet Chip Update Campaign pack can send a request via www.petchipupdate.com or call the AVID MicroChip sales line on 0800 652 7 977.
BCF Technology has launched the portable 9020HF Orange x-ray generator from Eco Ray.
BCF says the 9020HF is ideal for equine and large animal applications because it is is just marginally heavier than the 8016HF generator, but more powerful, allowing it to achieve excellent images of regions such as the stifle and spine.
The new BCF Clinical Development Manager and in-house vet Kimberly Palgrave said: "This new generator really fills the gap in the range and is an ideal balance between weight and power. It is also bright orange so impossible to miss when tidying the kit away in the yard."
BCF is also the sole official distributor in the UK and Ireland for Eco Ray generators.
To see the full range of X-ray generators and other X-ray and ultrasound equipment available from BCF visit http://www.bcftechnology.com/ or call +44 (0)1506 460023.
The RCVS Trust has announced 34 grants totalling approximately £165,000, being made to veterinary surgeons, universities and higher education (HE) establishments, to fund high-quality research projects in the UK and overseas, and support veterinary education.
Harper Adams University College and Myerscough College will be the first veterinary nursing colleges to receive funding under the Spencer-Hill equipment grants programme; this was the first time that RCVS-approved HE veterinary nurse training providers were able to apply for this funding. Harper Adams will receive £2,350 to purchase a Humphrey ADE-circle system, and Myerscough, £1,395 for an 'Emily' canine positioning mannequin.
Severine Tasker MRCVS, from the University of Bristol, and Janet Patterson-Kane MRCVS, from the University of Glasgow each received Blue Sky Awards of £17,000. Severine will conduct research into constructing defined feline coronavirus strains for determination of the role of virus genetics in the development of feline infectious peritonitis. Janet Patterson-Kane's research will investigate whether a new therapy for treating wounds in humans can be translated for use in horses.
Janet said: "Limb wounds in horses are very common and are notorious for developing masses of exuberant scar tissue - proud flesh - and not healing properly. This can necessitate multiple operations. The findings of current research at University College London by our collaborator, Professor David Becker, suggest that in human patients a protein, connexin 43, is not downregulated at the edges of wounds that are difficult to heal. Use of therapy to reduce connexin 43 expression in human skin wounds in which healing has stalled has been remarkably successful in achieving wound closure. The aim of our research is to determine if connexin 43 plays a similar key role as a 'master switch' for wound healing in horses. I am extremely grateful to the RCVS Trust for their support."
Six veterinary undergraduates will also receive EMS vacation research scholarships of £700 each, which can be used to fund expenses relating to a research project undertaken in the UK or overseas as part of a UK veterinary school's extra-mural studies requirement.
Full details of the RCVS Trust grant awards may be found at www.rcvstrust.org.uk/awards
The findings of a Canine Vector Borne Disease (CVBD) prevention field study, published in Veterinary Parasitology today, have demonstrated the efficacy of Advantix in repelling ticks and sandflies, thus reducing the risk of potentially deadly diseases.
The study, conducted over two years by a team headed by Professor Domenico Otranto of the Faculty of Veterinary Medicine (Universitá degli Studi di Bari) Italy, with diagnostic support from a team led by Dr. Edward Breitschwerdt at the North Carolina State University, USA, found that dogs treated regularly with Advantix spot-on had a greater than 90% reduction in CVBD cases, including a 100% reduction in new cases of potentially deadly leishmaniosis and a 94.6% decrease in ehrlichiosis.
The study also found that Advantix provided 97.9% protection against tick infestation, compared to untreated dogs, where 100% were infested at the peak of the season. The level of protection offered by Advantix was apparently all the more notable because of particularly large numbers of ticks and sand flies and high prevalence of associated diseases like leishmaniosis or babesiosis in the area of the study.
Prof. Otranto said: "Our study shows the importance of protecting dogs with an effective treatment that repels as well as kills parasites like ticks and sand flies. Despite the high challenge faced by the dogs in our study, nearly all our treated dogs remained free from ticks throughout most of the study, and more than 90% remained free from CVBDs for the whole study time.
"Because we included naïve sentinel beagles in the study, we were also able to model what would happen to dogs travelling to areas where CVBDs are present. We found that by the end of the study, only the Advantix-treated beagles remained protected from infection, while 80% of the untreated beagles were infected with a CVBD. This demonstrates the very real need to protect dogs that are travelling to endemic areas."
According to Bayer, the study showed some interesting results with dogs that were positive with CVBDs when they entered the study. Of these, half of those treated with Advantix were negative for CVBDs at the end of treatment, compared with only 13% of untreated dogs. This suggests the potential for natural clearance of CVBDs if a repellent treatment is used to prevent new transmissions.
Bayer says the study was extremely comprehensive, studying both indigenous and introduced naïve puppies, monitoring for several CVBDs and working with Dr. Breitschwerdt's team in the USA to use highly sensitive molecular testing techniques to ensure optimal diagnostic accuracy. Dr. Breitschwerdt said: "This is the most comprehensive study, to my knowledge, ever conducted testing the efficacy of a repellent ectoparasiticide to prevent the transmission of a spectrum of CVBDs in young dogs."
Leading parasitologist Dr. Luis Cardoso of the University of Trás-os-Montes e Alto Douro, Portugal said: "Thanks to this study we can see just how effective a treatment that repels as well as kills can be."
Horiba Medical has announced the addition of the Dr. Fritz Video-Compact-System for veterinary endoscopic applications to its range of animal healthcare products. According to the company, the system is suitable for everyday small animal practice and includes a base unit and video otoscope attachment with a range of accessories for various applications.
Both the 1/3" CCD video camera and cold light source are combined in one solid and easy to operate unit, whilst the single cable technology enables the transfer of clear, magnified endoscopic images to the monitor. The camera can also be used independent of the light source and combined with a standard microscope to display urine, haematological and cytological slides. The single cable technology is facilitated by the TWIN Lock connection which enables the cable to be connected to the endoscopes with a secure bayonet lock. Offering high mobility and flexibility during examinations, the single cable makes the examination of agitated and moving animals easier.
The Dr. Fritz Video-Compact-System includes a complete set of equipment for all otoscopic examinations. The 90° video otoscope attachment can be combined with six different examination sheaths, permitting the examination of ears, oral cavity and teeth. The combined suction and irrigation sheath enables the flushing of inflammation from the ear under visual control prior to topical treatment. Horiba says that with the working sheath, removal of foreign objects, biopsy and even dental examinations of smaller animals such as rodents is much faster, easier and more secure when following the enhanced visual display.
Optional endoscopes are also available for the Dr. Fritz Video-Compact-System, expanding the possible applications by adding rhinoscopic, bronchoscopic, cystoscopic and gynaecological functionality.
Horiba will be exhibiting the Dr. Fritz Video-Compact-System at the London Vet Show at Olympia, 22nd to 23rd October 2010, on Stand M4.
Organisers are calling for entrants for this year's Vet Charity Challenge, an outdoor sporting fundraiser which also serves as a team building event for practices.
Competitors take part in walking, running, cycling and kayaking challenges, along with some orienteering and mental and physical tasks, in teams of four.
The event will take place on Saturday 28th September at Pershore College, Worcestershire.
Organisers say the Vet Charity Challenge has been designed for every level of fitness and success on the day depends very much on how well each team member works together, rather than physical fitness.
Jason Rogers, one of the VCC organisers said: "Teams are registering every day and we are delighted with the response. But there are a few team spaces left, so I urge practices to register a team of four online now at: www.vetcharitychallenge.co.uk."
The Vet Charity Challenge 2012 raised a total of £21,000, which was shared between three animal charities. The event in 2013 will raise funds for Hearing Dogs for the Deaf, SPANA and Animals Asia.
Ceva Animal Health has launched Vectra 3D, a broad spectrum topical ectoparasiticide for dogs which is effective against fleas, ticks and flies.
Vectra 3D contains a formulation of a brand new active called dinotefuran, pyriproxyfen and permethrin.
According to the company, Vectra 3D provides a rapid flea kill within two hours for dogs on current treatment and complete protection against the major vectors: fleas, ticks, sand flies, mosquitoes and stable flies1. Additionally, because dinotefuran kills on contact, it is claimed to reduce the incidence of flea feeding1.
Vectra 3D is applied in a line from the base of the tail to the neck using a patented applicator with an elongated tip, designed to make it easy to apply the product through the hair directly onto the skin. The applicator is also designed to provide accurate dosing without making any mess, as nothing comes out until the tube is squeezed.
Ceva highlights that the number of people travelling with their pets has increased by 61% since 20122, and that Vectra 3D is the only topical ectoparasiticide that offers repellent action against sand flies for one month, together with protection against mosquitoes and stable flies.
Julia Wood, product manager at Ceva Animal Health said: "Vectra 3D is an innovative formulation which uses a unique, easy-to-administer applicator to provide complete protection against fleas, ticks and flies. And with spring nearly upon us, it's time to start talking to clients about flea treatments, such as Vectra 3D."
To support the launch of Vectra 3D, Ceva is hosting a series of CPD meetings at venues across the UK. Accounting for two hours CPD, the afternoon meetings will cover vector-borne diseases, the importance of ticks in the UK and product information on Vectra 3D. They will be presented by Ian Wright BVMS BSc MSc MRCVS and Richard Wall BSc MBA PhD FRES and take place at:
For further information, contact your Ceva Animal Health territory manager or email Ceva Animal Health on customerservicesuk@ceva.com.
An animal heath company is conducting a survey into veterinary surgeons' thoughts on digestive health conditions, including diarrhoea.
Everyone who participates in the survey will be entered into a prize draw to win £100 worth of John Lewis vouchers.
To take part, visit https://www.surveymonkey.com/s/digestive-health-survey.
The survey will remain live till 28th March 2014, and the results will be shared with participants in due course.
Sanofi-aventis and Merck & Co., Inc. announced today that Sanofi-aventis has exercised its option to combine Merial with Intervet/Schering-Plough, Merck's Animal Health business.
The new joint venture will be equally-owned by Merck and Sanofi-aventis. The formation of this new joint venture is subject to execution of final agreements, antitrust review in the United States, Europe and other countries, and other customary closing conditions. The completion of the transaction is expected to occur in approximately the next 12 months.
Richard T. Clark, Merck Chairman, President and Chief Executive Officer said: "Merck has been in the animal health business for well over six decades and through this new joint venture, we will bolster our diverse portfolio and create a new global competitor poised for growth.
"This new joint venture delivers on Merck's commitment to customer focus by creating one of the broadest portfolios of animal health products and services in pharmaceuticals and biologics for millions of customers who include farmers, veterinarians and pet owners. The planned joint venture will have an attractive geographical network of global technology and expertise to provide health solutions based on customers' needs, which often vary regionally."
The worldwide animal health market reached $19 billion in 2008. Products for companion animals accounted for 40 percent of total sales while products for production animals accounted for the remaining 60 percent of total sales. This market is expected to grow at around 5 percent per year over the next 5 years, driven by a growing demand for animal proteins, as well as a strong consumer needs for companion animal health care.
The companies said that both Merial and Intervet/Schering-Plough will continue to operate independently until the closing of the transaction.
The RCVS has announced that the nomination period for the 2015 RCVS and VN Council elections has opened until 5:00pm on Saturday 31 January 2015.
Each year six RCVS Council seats are contested while two seats are available for VN Council. Successful candidates serve four-year terms.
Existing RCVS Council members Niall Connell, Professor Sheila Crispin, Mark Elliott, Lynne Hill, Dr Bob Moore and Professor the Lord Trees of the Ross are due to retire from Council next year but are all eligible for re-election. Elizabeth Branscombe and Elizabeth Cox are due to retire from VN Council but will also be eligible to stand again in 2015.
In order to stand, candidates for either RCVS or VN Council will need to complete a nomination form, submit a short biography, write a short personal statement and supply a high resolution digital photo.
Each candidate will also need to provide two nominations - for RCVS Council candidates this should be two veterinary surgeons on the RCVS Register who are not current RCVS Council members; for VN Council candidates nominators must be registered or listed VNs who are not current VN Council members.
The election period commences in early March 2015 and runs until Friday 24 April. Successful candidates for either Council will take up their seats at RCVS Day - the College's Annual General Meeting and Awards Day - on Friday 10 July 2015.
Gordon Hockey, RCVS Registrar, said: "After a record 19 candidates - of which over half were women - for last year's RCVS Council elections, and a good showing for VN Council as well, we hope to build on that momentum this year by attracting candidates of all ages and backgrounds.
"Through their participation in the Councils and their committees members can have a big impact on the future of their respective professions by developing policy and making decisions in areas of key importance such as education and professional standards."
Nomination forms, guidance notes and frequently asked questions for RCVS Council candidates can be found at www.rcvs.org.uk/rcvscouncil15. The equivalent documents for VN Council candidates can be found at www.rcvs.org.uk/vncouncil15.
Last year the RCVS produced two short videos outlining what is involved in being a Council member, the benefits it can bring and the amount of time it requires. These can be found at www.youtube.com/rcvsvideos
Prospective candidates are also invited to attend a 'Meet the RCVS Day' at Belgravia House on Tuesday 25 November where they will have the opportunity to find out more about the role of the College and RCVS and VN Council members as well as having a tour of the building and the opportunity to talk to staff.
Those who are interested in attending should contact Fiona Harcourt, Events Officer, on f.harcourt@rcvs.org.uk or 020 7202 0773.
Hysolv Animal Health UK has announced that it is offering a free diagnostic test which allows vets to identify the E. coli sub-types that produce the Shiga toxin associated with oedema disease in pigs.
The test, known as STEC-Check and worth £150-£200, is being sponsored by IDT Biologika GmbH. In the UK and Republic of Ireland, faeces and/or intestinal samples will be sent to the Animal Health and Plant Agency (APHA), Weybridge and SAC Consulting Veterinary Services at Penicuik to confirm results within a few days.
Hysolv says the test will provide a quick and accurate diagnosis, enabling appropriate action, including vaccination, to be taken on the farm.
Richard Brealey from Hysolv said: "Oedema disease is not always obvious and may be masked or controlled by the use of antibiotics, the use of zinc oxide or low-protein feeds which can also negatively affect productivity. This test will help confirm the presence of Shiga-toxin producing E. coli on the farm, a cause of serious losses in individual herds. We are therefore advising farmers to contact their vets to discuss using STEC-check on their farms."
According to the company, a nationwide study in Germany showed that 59% of farms where oedema was suspected were affected by Shiga toxin.
Richard added: "The Ecoporc Shiga vaccine has been recently licensed for use in the UK. There is pressure on vets and farmers to reduce the use of antimicrobials and vaccination, together with other measures, and this will help them to do this."
In the UK farmers will be able to carry out a DIY calculation of their return on investment online, using their smartphones or by visiting the Shiga toxin website www.shigatoxin.com
Four separate studies are included in the collection, reporting novel risk factors for the disease, identifying key differences between EGS and botulism (questioning the hypothesis that EGS is caused by neurotoxins from Clostridium botulinum), reporting a novel diagnostic technique and showing the value of monitoring weight loss to help predict whether individual horses with chronic EGS are likely to survive.
The publishers say that despite more than 100 years of research, supported predominantly by the The Moredun Foundation Equine Grass Sickness Fund (www.grasssickness.org.uk), the cause of EGS remains unknown. Since it almost exclusively affects grazing horses, a pasture derived neurotoxin is implicated. EGS causes gut paralysis as a result of damage to parts of the nervous system that control involuntary functions. Acute and sub-acute EGS is invariably fatal while around 55% of chronic cases can survive and return to a useful working life. The UK has the highest incidence of EGS in the world; indeed it is estimated that the disease kills between 1 and 2% of horses in the United Kingdom annually. Cases are more common in spring.
In terms of risk factors, the study ‘Equine grass sickness in Scotland: A case-control study of environmental geochemical risk factors’ suggests that the high incidence of the disease in Eastern Scotland may be partly associated with the particular composition of macro and trace elements in the soil in the fields on which horses graze. Further work is required to determine whether interventions to alter concentrations of particular elements in soil could potentially reduce the risk of EGS.1
A second study identified key differences between EGS and botulism, which questions the currently favoured hypothesis that EGS is caused by neurotoxins from Clostridium botulinum, a bacterium which commonly inhabits soil. The study ‘Equine grass sickness, but not botulism, causes autonomic and enteric neurodegeneration and increases soluble N-ethylmaleimide-sensitive factor attachment receptor protein expression within neuronal perikarya’ suggests that EGS is unlikely to be caused by neurotoxins from this bacterium and concludes that further investigation of an alternative cause for EGS is needed.2
While the majority of horses with EGS can be readily diagnosed by experienced veterinary surgeons, some cases present a diagnostic challenge. Indeed the only way to definitively diagnose the disease in a live horse is to demonstrate the characteristic degeneration of nerves within biopsies of the intestine. Unfortunately these biopsies can only be collected by performing abdominal surgery under general anaesthesia. In the study ‘Neuronal chromatolysis in the subgemmal plexus of gustatory papillae in horses with grass sickness’ characteristic degeneration of nerves was identified in small biopsies collected from tongues of EGS horses during post mortem examination. Examination of these biopsies accurately differentiated control horses from EGS cases. While further validation of this technique is required, it could potentially provide a relatively non-invasive method of confirming the diagnosis in a live horse.3
While around 55% of horses with chronic EGS survive, objective criteria for predicting survival of these cases are currently lacking. The study ‘Bodyweight change aids prediction of survival in chronic equine grass sickness’ reported that non-survivors had greater rate and magnitude of bodyweight loss than survivors. Survival prediction curves were published to allow veterinary surgeons and horse owners to use body weight data to help determine whether an individual horse with chronic EGS was likely to survive or die.4
Professor Bruce McGorum, Head of the Equine Section at the Royal (Dick) School of Veterinary Studies & Roslin Institute in Edinburgh, has been leading much of the research. He said: "Given that our recent research suggests that EGS is unlikely to be caused by neurotoxins from Clostridium botulinum we are now moving on to determine whether EGS is caused by ingestion of mycotoxins produced by pasture fungi. We are very pleased that The Horse Trust (www.horsetrust.org.uk) has provided funding for this three-year investigation."
Professor Celia Marr, Editor of the Equine Veterinary Journal said: “While the cause of equine grass sickness continues to evade us, these papers present an optimistic step in the right direction for the eventual prevention of this dreadful disease. It is only with the support of the Moredun Foundation Equine Grass Sickness Fund and more recently that of The Horse Trust that our world-leading veterinary researchers are able to continue to unravel the mystery.”
The EVJ equine grass sickness collection can be downloaded at http://bit.ly/2dC7Drr
References
At the same time as paying the fee, all veterinary surgeons must annually confirm their Register and correspondence details, declare any convictions, cautions or adverse findings and confirm they are compliant with RCVS continuing professional development (CPD) policy.
The deadline for completing the annual renewal, 1 April 2019, has now passed and all veterinary surgeons who are yet to pay their fees must do so before the end of May 2019. As of 1 June 2019, any non-payers will be removed from the Register.
If paid by 30 April 2019, the annual fee is £340 for UK-practising veterinary surgeons, £170 for veterinary surgeons practising outside the UK, and £56 for non-practising veterinary surgeons. Following this date, the fee goes up by £35 across all these groups and veterinary surgeons will have until 31 May 2019 to pay.
If the renewal fee is not received in full by 31 May 2019, then non-paying veterinary surgeons will be removed from the Register. In order to restore their name to the Register, a restoration fee of £340 will need to be paid, in addition to the appropriate retention fee. During this time they will not be able to use the postnominals MRCVS and UK-practising vets will need to cease practising.
Annual renewals can be completed online on the RCVS website and all the information needed to complete the annual renewal is in the renewal notice that has been sent to veterinary surgeons. Those who need any help or have any questions about completing their renewal and paying fees should contact the RCVS Registration Department on 020 7202 0707 or registration@rcvs.org.uk.
For veterinary surgeons and VNs who missed out on the BVDA 'Improving Periodontal Health' lecture tour last year, a further six have been organised for this autumn.
Speakers include Norman Johnston BVM&S, MRCVS, Ex President of the European Veterinary Dental College, John Robinson BDS (Lond) Dentist to the Veterinary Profession and Lisa Milella BVSc, MRCVS President of the British Veterinary Dental Association (BVDA). This year's events see the content extended to include resorptive lesions, fractured teeth and dental radiography with greater emphasis on feline oral care.
According to Lisa, the 2010 lecture series helped alert vets and VNs to the importance of oral health, benefitting both pet and practice. "It takes five years at vet school to qualify yet only three or four days are devoted to dentistry, so it's no surprise that many vets and VNs enter the profession with only a basic understanding of oral health.
"We know that four out of five dogs over the age of three show signs of periodontal disease but unfortunately many go untreated. This is mainly because the problems that this can lead to are not fully understood."
She added: "These seminars will not only help delegates to recognise early signs of oral disease but also offer practical guidance on how practices can educate pet owners in the importance of oral care."
Lisa believes that both practices and owners benefit from good oral hygiene programmes. "As a profession we need to do more to help educate pet owners in the value of good oral care. Practices should be talking to their clients from day one about preventative programmes, rather than wait until the damage is done."
The six UK events are:
The evening seminars, which are open to both vets and nurses, contribute two hours CPD and cost £35 per person and £25 for each subsequent delegate. A special group rate of £100.00 is available for any practice that wishes to send a group of four. For anyone wanting to reserve a place, please call the BVDA lecture tour reservation line centre on 01664 415 503.
Open to everyone in the profession, Congress '24 will include over 130 hours of CPD across 32 different modules covering topics such as advanced diabetes, dermatology, nursing clinics, EDI and more.
The programme format caters to a variety of learning styles, from lectures and panel discussions to interactive sessions and free CPD workshops.
There'll be over 120 exhibitors in three commercial exhibition, offering insights into some of the latest industry innovations, from pharmaceuticals to cutting-edge equipment.
Andy Green, Chair of the Congress Committee said: "We know it's a significant commitment for individuals to give up one to three days, plus travel time, to join us, and we don't just aim to educate; we want our attendees to enjoy the experience.
"Our aspiration is not just to meet their expectations but to exceed them.
"The veterinary profession faces challenges, but we have so much to celebrate, and what better place to come together with many like-minded individuals to remind yourself why you wanted to be in this profession in the first place."
Early bird registration is open until 31st January, and prices start at £93 +VAT for BSAVA members for a one-day pass.
www.bsavacongress.com
There had already been a gap in supply of the vaccine between June and August due to a batch being out of specification.
The company says it submitted an Out of Specification request to release the vaccine but was unsuccessful.
The next delivery of vaccine was expected at the end of August, however this has unfortunately been delayed until October, and there is no certainty of this delivery.
Ceva says it deeply regrets the inconvenience caused to sheep farmers this year.
Roy Geary, Vice President for Northern Europe (including the UK) at Ceva Animal Health, said: “The manufacturing of vaccines is a complex process that involves stringent quality control measures and adherence to regulatory guidelines.
"There have been unforeseen manufacturing issues at our production facilities, which have temporarily affected the ability to meet the demands of the UK sheep market within the main seasonal vaccination period for EAE.
"As a responsible provider, we are actively addressing these issues to minimise the impact on customers.”
“We are recommending that vets and farmers follow the advice published on 24th July 2024 from the Sheep Vet Society and Sheep Antibiotic Guardian Group (SAGG).”
https://sheepvetsoc.org.uk/news/sheep-veterinary-society-svs-and-sheep-antibiotic-guardian-group-sagg-advice-for-when-an-enzootic-abortion-eae-vaccine-is-unavailable.